153 related articles for article (PubMed ID: 27695439)
21. Liposome-encapsulated plasmid DNA of telomerase-specific oncolytic adenovirus with stealth effect on the immune system.
Aoyama K; Kuroda S; Morihiro T; Kanaya N; Kubota T; Kakiuchi Y; Kikuchi S; Nishizaki M; Kagawa S; Tazawa H; Fujiwara T
Sci Rep; 2017 Oct; 7(1):14177. PubMed ID: 29074882
[TBL] [Abstract][Full Text] [Related]
22. Improved pharmacokinetics and reduced toxicity of brucine after encapsulation into stealth liposomes: role of phosphatidylcholine.
Chen J; Yan GJ; Hu RR; Gu QW; Chen ML; Gu W; Chen ZP; Cai BC
Int J Nanomedicine; 2012; 7():3567-77. PubMed ID: 22904620
[TBL] [Abstract][Full Text] [Related]
23. Liposomes encapsulated iridium(III) polypyridyl complexes enhance anticancer activity in vitro and in vivo.
Bai L; Fei WD; Gu YY; He M; Du F; Zhang WY; Yang LL; Liu YJ
J Inorg Biochem; 2020 Apr; 205():111014. PubMed ID: 32044395
[TBL] [Abstract][Full Text] [Related]
24. Co-delivery of doxorubicin and PSC 833 (Valspodar) by stealth nanoliposomes for efficient overcoming of multidrug resistance.
Bajelan E; Haeri A; Vali AM; Ostad SN; Dadashzadeh S
J Pharm Pharm Sci; 2012; 15(4):568-82. PubMed ID: 23106959
[TBL] [Abstract][Full Text] [Related]
25. Investigation of nano lipid vesicles of methotrexate for anti-rheumatoid activity.
Prabhu P; Shetty R; Koland M; Vijayanarayana K; Vijayalakshmi KK; Nairy MH; Nisha GS
Int J Nanomedicine; 2012; 7():177-86. PubMed ID: 22275833
[TBL] [Abstract][Full Text] [Related]
26. The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats.
Dadashzadeh S; Vali AM; Rezaie M
Int J Pharm; 2008 Apr; 353(1-2):251-9. PubMed ID: 18191511
[TBL] [Abstract][Full Text] [Related]
27. Reparative and toxicity-reducing effects of liposome-encapsulated saikosaponin in mice with liver fibrosis.
Shiu LY; Huang HH; Chen CY; Cheng HY; Chen CI; Kuo SM
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32756863
[TBL] [Abstract][Full Text] [Related]
28. Asialoglycoprotein receptor-targeted liposomes loaded with a norcantharimide derivative for hepatocyte-selective targeting.
Liu X; Han M; Xu J; Geng S; Zhang Y; Ye X; Gou J; Yin T; He H; Tang X
Int J Pharm; 2017 Mar; 520(1-2):98-110. PubMed ID: 28167263
[TBL] [Abstract][Full Text] [Related]
29. Encapsulation of the topoisomerase I inhibitor GL147211C in pegylated (STEALTH) liposomes: pharmacokinetics and antitumor activity in HT29 colon tumor xenografts.
Colbern GT; Dykes DJ; Engbers C; Musterer R; Hiller A; Pegg E; Saville R; Weng S; Luzzio M; Uster P; Amantea M; Working PK
Clin Cancer Res; 1998 Dec; 4(12):3077-82. PubMed ID: 9865923
[TBL] [Abstract][Full Text] [Related]
30. Bacteria-targeting liposomes for enhanced delivery of cinnamaldehyde and infection management.
Sang N; Jiang L; Wang Z; Zhu Y; Lin G; Li R; Zhang J
Int J Pharm; 2022 Jan; 612():121356. PubMed ID: 34919996
[TBL] [Abstract][Full Text] [Related]
31. Hyperthermia induces doxorubicin release from long-circulating liposomes and enhances their anti-tumor efficacy.
Ning S; Macleod K; Abra RM; Huang AH; Hahn GM
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):827-34. PubMed ID: 8040030
[TBL] [Abstract][Full Text] [Related]
32. Antimicrobial activity of β-lapachone encapsulated into liposomes against meticillin-resistant Staphylococcus aureus and Cryptococcus neoformans clinical strains.
Cavalcanti IM; Pontes-Neto JG; Kocerginsky PO; Bezerra-Neto AM; Lima JL; Lira-Nogueira MC; Maciel MA; Neves RP; Pimentel MF; Santos-Magalhães NS
J Glob Antimicrob Resist; 2015 Jun; 3(2):103-108. PubMed ID: 27873657
[TBL] [Abstract][Full Text] [Related]
33. Formulation of plumbagin loaded long circulating pegylated liposomes: in vivo evaluation in C57BL/6J mice bearing B16F1 melanoma.
Kumar MR; Aithal BK; Udupa N; Reddy MS; Raakesh V; Murthy RS; Raju DP; Rao BS
Drug Deliv; 2011; 18(7):511-22. PubMed ID: 21793763
[TBL] [Abstract][Full Text] [Related]
34. In vitro comparison of liposomal drug delivery systems targeting the oxytocin receptor: a potential novel treatment for obstetric complications.
Hua S; Vaughan B
Int J Nanomedicine; 2019; 14():2191-2206. PubMed ID: 30988616
[TBL] [Abstract][Full Text] [Related]
35. Tumor microenvironment responsive VEGF-antibody functionalized pH sensitive liposomes of docetaxel for augmented breast cancer therapy.
Jain S; Deore SV; Ghadi R; Chaudhari D; Kuche K; Katiyar SS
Mater Sci Eng C Mater Biol Appl; 2021 Feb; 121():111832. PubMed ID: 33579470
[TBL] [Abstract][Full Text] [Related]
36. Preparation, characterization, and anti-colon cancer activity of oridonin-loaded long-circulating liposomes.
Gao C; Zhang L; Tang Z; Fang Z; Ye X; Yu W
Pharm Dev Technol; 2021 Dec; 26(10):1073-1078. PubMed ID: 34543167
[TBL] [Abstract][Full Text] [Related]
37. Long-circulating liposome-encapsulated ganciclovir enhances the efficacy of HSV-TK suicide gene therapy.
Kajiwara E; Kawano K; Hattori Y; Fukushima M; Hayashi K; Maitani Y
J Control Release; 2007 Jul; 120(1-2):104-10. PubMed ID: 17509714
[TBL] [Abstract][Full Text] [Related]
38. Membrane interactions of ternary phospholipid/cholesterol bilayers and encapsulation efficiencies of a RIP II protein.
Manojlovic V; Winkler K; Bunjes V; Neub A; Schubert R; Bugarski B; Leneweit G
Colloids Surf B Biointerfaces; 2008 Jul; 64(2):284-96. PubMed ID: 18359207
[TBL] [Abstract][Full Text] [Related]
39. Development of stealth liposomal formulation of celecoxib: In vitro and in vivo evaluation.
Begum MY; M Osmani RA; Alqahtani A; Ghazwani M; Hani U; Ather H; Atiya A; Rahamathulla M; Siddiqua A
PLoS One; 2022; 17(4):e0264518. PubMed ID: 35472207
[TBL] [Abstract][Full Text] [Related]
40. Liposomal Doxorubicin: the Sphingomyelin/Cholesterol System Significantly Enhances the Antitumor Efficacy of Doxorubicin.
Meng X; Zhang H; Chen L; Wang M; Zhang K; Liu X; Deng Y; Song Y
AAPS PharmSciTech; 2023 Feb; 24(2):64. PubMed ID: 36759405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
